Latest in News & Research
Child’s Atopic Dermatitis Linked to Maternal Depression Scores
Association stronger among mothers from lower socioeconomic backgrounds managing severe child AD in early childhood
FDA Approves Zoryve for Atopic Dermatitis in Young Children
The once-daily cream can be used anywhere on the body and offers an alternative to steroids in children ages 2 to 5 years
A New Era for Dermatology PAs and NPs Begins with PANP360
The one-of-a-kind platform unites peer connection, clinical learning, and purpose under one home
Cash Balance Plans: A Strategic Retirement Option for High-Earning Dermatologists
Are you a high-earning dermatologist wondering if you’re truly maximizing your retirement savings? What if there was a way to potentially enhance your nest...
Cosibelimab Tied to Robust, Durable Response for Cutaneous Squamous Cell Carcinoma
Findings seen for patients with metastatic or locally advanced disease, with low rates of severe immune-related adverse events
Some Patients With Alopecia Achieve Treatment Success After Switching JAKis
Authors say conclusions cannot be drawn regarding the frequency of treatment failure or success of the JAKis
Hyaluronic Acid Fillers Restore Facial Volume, Fullness
Greatest volume maintenance seen in the midface and greatest loss around the mimetic areas
FDA Approves Tremfya for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
40 percent of children achieved complete skin clearance at week 16 with Tremfya versus placebo
Dermsquared Appoints April Armstrong, MD, MPH, as Editor-in-Chief of the Dermatology Online Journal
April Armstrong, MD, MPH, announced as Editor-in-Chief of Dermatology Online Journal
Mediterranean Diet Tied to Improvement in Psoriasis
Sixteen-week intervention showed significant improvement in Psoriasis Area and Severity Index
Higher Tattoo Exposure Linked to Reduced Melanoma Risk
Overall melanoma risk lower for those who had received four or more tattoo sessions, had three or more large tattoos
FDA Approves Opzelura for Atopic Dermatitis in Children
It is the first topical JAK inhibitor approved in the U.S. for pediatric atopic dermatitis
GLP-1 Receptor Agonists Tied to Reduced Mortality in Patients With Psoriasis
Risk reductions stronger in those with psoriasis versus those with obesity or type 2 diabetes without psoriasis
Combo Microfocused US, Microneedle Fractional Radiofrequency Safe, Effective for Facial Rejuvenation
High satisfaction seen with combined microfocused ultrasound and microneedle fractional radiofrequency
'Rule Out Melanoma' Terminology Has Low Positive Predictive Value for Melanoma Diagnosis
Only 13.41 percent of biopsies labeled ROM were histologically confirmed as melanoma, most of which were melanoma in situ
Painful, Blistering, Severe Sunburn Tied to Higher Risk for Squamous Cell Carcinoma
Findings seen for any history of severe sunburn, including during childhood
Novel Oral Supplement Boosts Effect of Pharmacological Treatment for Alopecia
Increased clinical efficacy seen for adults with androgenic alopecia or female androgenic alopecia
AMD Risk Increases With Psoriasis
Risk for unspecified AMD lower for those treated with biologics versus topical corticosteroids alone
Skin Cancer Risk Reduced for Patients Treated With Nicotinamide
Greatest effect was seen when nicotinamide was initiated after the first skin cancer
Tool With 14 Predictors Improves Prediction of Invasive Melanoma
Best-fitting model includes 14 predictors and two statistical terms, yielding discriminatory accuracy of 0.74
Eczema Recurrence Rate of 23.4 Percent Reported After Discontinuing Dupilumab
Predictors with significant effect on recurrence include allergic conjunctivitis, duration of treatment <16 weeks, male sex
Poor Cardiovascular-Kidney-Metabolic Health Increases Psoriasis Risk
Significantly higher risk for psoriasis noted, especially among those with high genetic risk
Image-Based System Reliable for Evaluating Vitiligo Lesions
UV-image Target-VASIs demonstrated strong correlations with tracing paper and clinician Target-VASIs
24 of 1200